Arcus Capital Partners, LLC Pfizer Inc Transaction History

Arcus Capital Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$41.75 - $54.5 $29,016 - $37,877	695 New	695 $0
Q4 2018 Feb 11, 2019	BUY	$38.47 - $43.86 $17,234 - $19,649	448 Added 9.25%	5,290 $231,000
Q3 2018 Nov 09, 2018	BUY	$34.47 - $41.81 $166,903 - $202,444	4,842 New	4,842 $213,000
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $303,416 - $323,471	-9,200 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $128,086 - $148,598	-4,014 Reduced 30.38%	9,200 $326,000
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $18,658 - $19,797	-561 Reduced 4.07%	13,214 $479,000
Q3 2017 Nov 15, 2017	BUY	$31.0 - $34.15 $427,025 - $470,416	13,775	13,775 $492,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Arcus Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Arcus Capital Partners, LLC with notifications on news.